Home › Attention Deficit Hyperactivity Disorder › Kentucky
Attention Deficit Hyperactivity Disorder clinical trials in Kentucky
3 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in Kentucky.
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- Kentucky Pediatric/Adult Research, Bardstown
- Qualmedica Research, LLC., Owensboro
RecruitingPhase 4
48 Months – 69 Months · All sexes · Updated Sep 11, 2026 · NCT04781140Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Clinical Research Site, Bardstown
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Sep 8, 2026 · NCT07717892Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Clinical Research Site, Bardstown
RecruitingPhase 3
Ages 6 to 11 · All sexes · Updated Sep 8, 2026 · NCT07717879From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.